Niosomes: Novel sustained release nonionic stable vesicular systems - An overview

Advances in Colloid and Interface Science

Volumn 183-184, Issue , 2012, Pages 46-54

  Mahale, N B ^a   Thakkar, P D ^a   Mali, R G ^b   Walunj, D R ^c   Chaudhari, S R ^a  

^a Amrutvahini College of Pharmacy   (India)

^b LB Rao Institute of Pharmaceutical Education and Research   (India)

^c SND College of Pharmacy   (India)

Author keywords

Cholesterol impact; Drug delivery; Niosome; Non toxic; Nonionic surfactant

Indexed keywords

BIOCHEMISTRY; CHOLESTEROL; DRUG DELIVERY; GENE TRANSFER; NONIONIC SURFACTANTS; TARGETED DRUG DELIVERY;

ANTI-CANCER DRUG DELIVERY; CHOLESTEROL IMPACTS; MANUFACTURING CONDITIONS; NIOSOME; NON-TOXIC; SUSTAINED RELEASE; THERAPEUTIC EFFECTS; VACCINE DELIVERY;

CONTROLLED DRUG DELIVERY;

EID: 84866376620     PISSN: 00018686     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cis.2012.08.002     Document Type: Review

References (82)

1. P.K. Gannu, and P. Rajeshwarrao Nonionic surfactant vesicular systems for effective drug delivery an overview Acta Pharmacol Sin 1 4 2011 208 219
2. L.M. Negi, A.K. Garg, and M. Chauhan Ultra deformable vesicles: concept and execution Pharm Times 41 2009 11 14
3. V. Sankar, K. Ruckmani, S. Jailan, K.S. Ganesan, and S. Sharavanan Niosome drug delivery system: advances and medical applications an overview Pharmacol Online 2 2009 926 932
4. I.F. Uchegbu, and S.P. Vyas Non-ionic surfactant based vesicles (niosomes) in drug delivery Int J Pharm 172 1998 33 70
5. I.F. Uchegbu, and A.T. Florence Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry Adv Colloid Interface Sci 58 1995 1 55
6. J.A. Bouwstra, H.D. Van, and H.E. Hofland Preparation and characterization of non ionic surfactant vesicles Colloids Surf A Physicochem Eng Asp 80 1997 123 124
7. M. Rangasamy, B. Ayyasamy, S. Raju, S.G. Develly, and S. Shaik Formulation and in vitro evaluation of noisome encapsulated acyclovir J Pharm Res 1 2008 163 166
8. S. Bhaskaran, and P.K. Lakshmi Comparative evaluation of niosome formulations prepared by different techniques Acta Pharm Sci 51 2009 27 32
9. K. Wadhe, R. Kalsait, and M. Umekar Alternate drug delivery system: recent advancement and future challenges Arch Pharm Sci Res 1 2009 97 105
10. A. Bajaj, and M. Desai Challenges and strategies in novel drug delivery technologies Pharm Times 38 2006 12 16
11. V. Sankar, K. Ruckmani, S. Durga, and S. Jailani Proniosomes as drug carriers Pak J Pharm Sci 23 2010 103 107
12. A.T. Florence New drug delivery systems Chem Ind 20 December 1993 1000 1004
13. G. Buckton Interfacial phenomena in drug delivery and targeting 1995 Harwood Academic Publishers Switzerland 154 155
14. J. Jiao Poly oxy ethylated non ionic surfactants and their applications in topical ocular drug delivery Adv Drug Deliv Rev 60 2008 1663 1673
15. G. Zografi Interfacial phenomena A.R. Gennaro, Remington: the science and practice of pharmacy 17th ed. 1995 Mark Publishing Pennsylvania 241 251
16. D.G. Hal Thermodynamics of micelle formation M.J. Schick, Nonionic surfactants: physical chemistry, surfactant science series. vol. 23 1987 Marcel Dekker New York 233 296
17. S. Zhang, and M.E. Morri Efflux transporters in drug excretion B. Wang, T. Siahaan, R. Soltero, Drug delivery: principles and applications 2005 John Wiley & Sons New Jersey 381 398
18. G. Valnerberghe, R.M. Hindjani-villa, and A. Ribier Colloq Nationaux CNRS 938 1978 20
19. A. Rogerson, J. Cummings, and A.T. Florence J Microencapsulation 4 1987 321
20. A. Pardakhty, J. Varshosaz, and A. Rouholamini In vitro study of poly oxy ethylene alkyl ether niosomes for delivery of insulin Int J Pharm 328 2007 130 141
21. I.F. Uchegbu, J.A. Double, J.A. Turton, and A.T. Florence Pharm Res 172 1998 33 70
22. A. Lavergne, Y. Zhu, A. Pizzino, V. Molinie, and J.M. Aubry Synthesis and foaming properties of new anionic surfactants based on are new able building block: sodium do-decyl isosorbide sulfates J Colloid Interface Sci 360 2011 645 [53]
23. C.R. Raymzond, J.S. Paul, and C.O. Sian Poly oxy ethylene alkyl ethers Handbook of pharmaceutical excipients 5th ed. 2006 Pharmaceutical Press London 564 571
24. A. Manosroi, P. Wongtrakul, J. Manosroi, H. Sakai, F. Sugawara, and N. Yuasa Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol Colloids Surf B Biointerfaces 30 2003 129 138
25. M. Manconi, D. Valenti, C. Sinico, F. Lai, G. Loy, and A.M. Fadda Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photo stability Int J Pharm 260 2003 261 272
26. M. Manconi, C. Sinico, D. Valenti, G. Loy, and A.M. Fadda Niosomes as carriers for tretinoin. I. Preparation and properties Int J Pharm 234 2002 237 248
27. S. Daneshamouz, M. Tabbakhian, N. Tavakoli, and M.R. Jaafari Influence of liposomes and niosomes on the in vitro permeation and skin retention of finasteride Iran J Pharm Sci 1 2005 119 130
28. A. Pardakhti, M.H. Moshefi, and H. Moteshafi Preparation of niosomes containing chloramphenicol sodium succinate and evaluation of their physicochemical and antimicrobial properties Pharm Sci 1 Spr. 2007 11 21
29. P. Balakrishnan, S. Shanmugam, W.S. Lee, and W.M. Lee Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery Int J Pharm 377 2009 1 8
30. A.S. Guinedi, N.D. Mortada, S. Mansour, and R.M. Hathout Preparation and evaluation of reverse-phase evaporation and multi-lamellar niosomes as ophthalmic carriers of acetazolamide Int J Pharm 306 2005 71 82
31. T. Yoshioka, and A.T. Florence Int J Pharm 108 1994 117
32. T. Yoshioka, M. Gruse, and A.T. Florence J Drug Target 2 1995 533
33. S.K. Hait, and S.P. MAulik Gemini surfactants: a distinct class of self assembling molecules Curr Sci 82 2002 1101 1111
34. I. Ikeda Synthesis of Gemini and elated substances R. Zana, J. Xia, Gemini surfactants synthesis, interfacial and solution phase-behavior, and applications 1 2003 Marcel Dekker New York 26 30
35. Y. Yan, L. Ting, and J. Huang Recent advances in bolaamphiphiles and oppositely charged conventional surfactants J Colloid Interface Sci 337 2009 1 10
36. L. Carol, and A.V. Keita Translocation of Crohn's disease Escherichia coli across M cells: contrasting effects of soluble plant fibers and emulsifiers Gut 59 2010 1331 1339
37. T. Yoshioka, B. Stermberg, and A.T. Florence Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85) Int J Pharm 105 1994 1 6
38. M.J. Lawrence, S. Chauhan, S.M. Lawrence, and D.J. Barlow The formation, characterization and stability of non-ionic surfactant vesicles STP Pharm Sci 1 1996 49 60
39. S. Biswal, P.N. Murthy, J. Sahu, P. Sahoo, and F. Amir Vesicles of non-ionic surfactants (niosomes) and drug delivery potential Int J Pharm Sci Nanotechnol 1 2008 1 8
40. A. Shahiwala, and A. Misra Studies in topical application of niosomally entrapped nimesulide J Pharm Sci 5 2002 220 225
41. C.A. Hunter, T.F. Dolan, G.H. Coombs, and A.J. Baillie Vesicular systems (niosome and liposomes) for delivery of sodium stibo gluconate in experimental murine visceral leishmaniasis J Pharm Pharmacol 40 1988 161 165
42. B. Nasseri Effect of cholesterol and temperature on the elastic properties of niosomal membranes Int J Pharm 300 2005 95 101
43. R.M. Handjani-Vila Non-ionic vesicles as drug delivery systems Fifth International Pharmaceutical Technology Symposium September 1990, Ankara 1990
44. Uchegbu IF. Phd Thesis, School of Pharmacy, University of London, 1994.
45. T. Yoshioka, B. Sternberg, and A.T. Florence Int J Pharm 105 1994 1
46. H. Talsma, M.J. Van Stenberg, J.H.C. Brochert, and D. Crommelin J Pharm Sci 83 1994 216
47. H.J. Hinz, H. Kuttenreich, R. Mayer, M. Renner, and R. Frund Biochemistry 30 1991 5125
48. Cable C. Phd Thesis, University of strathelyde, Glasgow, 1989.
49. T. Liu, R. Guo, W. HUa, and J. Qui Structure behaviors of hemoglobin in PEG6000/Tween80/Span80/H2O niosome system Colloid Surf A Physicochem Eng Aspects 293 2007 255 261
50. A.A. Shtil, T.M. Grinchuk, and L. Tee Over expression of P-glycoprotein is associated with a decreased mitochondrial Trans membrane potential in doxorubicin selected K562 human leukemia cells Int J Oncol 17 2000 387 392
51. M. Mokhtar, O.A. Amour, M.A. Hammed, and N.A. Megrab Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes Int J Pharm 361 2008 104 111
52. A.G. Baillie, G.H. Coombs, T.F. Dolan, and J. Laurie Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti leishmanial drug, sodium stibogluconate J Pharm Pharmacol 38 1986 502 505
53. A.J. Baillie, A.T. Florence, L.R. Hume, G.T. Muirhead, and A. Rogerson The preparation and properties of niosomes non-ionic surfactant vesicles J Pharm Pharmacol 37 1985 863 868
54. Duncan R, Florence A, Uchegbu I, Cociacinch F, 1997. Drug Polymer conjugates encapsulated within niosomes. International Patent Application PCT: GB97:00072.
55. E. Gianasi, F. Cociancich, I.F. Uchegbu, A.T. Florence, and R. Duncan Pharmaceutical and biological characterization of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes Int J Pharm 148 1997 139 148
56. S. Bhaskaran, and P.K. Lakshmi Comparative evaluation of niosome formulations prepared by different techniques Acta Pharm Sci 51 2009 27 32
57. J.F. Martin Pharmaceutical manufacturing of liposomes P. Tyle, Specialized drug delivery systems manufacturing and production technology 1990 Marcel Dekker New York 267 314
58. N. Ahuja, V. Saini, V.K. Bishnoi, A. Garg, M. Hisoria, and J. Sharma Formulation and evaluation of lansoprazole niosome Rasayan J Chem 1 2008 561 563 [62]
59. S. Gyanendra, D. Harinath, K.S. Shailendra, and A.S. Shubhini Niosomal delivery of isoniazide development and characterization Trop J Pharm Res 10 2011 203 210
60. Michael W, Gerhard W, Heinrich H, Klaus D. Liposome preparation by single-pass process. US patent 20100316696 A1; 2010.
61. K.M. Karim, A.S. Mandal, N. Biswas, A. Guha, S. Chatterjee, and M. Behera Niosome: a future of targeted drug delivery systems J Adv Pharm Technol Res 1 2010 374 380 [64]
62. L.S. Frank, and L. Huang Large scale production of DC Chol cationic liposomes by micro fluidization Int J Pharm 144 1996 131 139
63. A.H. Sathali, and G. Rajalakshmi Evaluation of transdermal targeted niosomal drug delivery of terbinafine hydrochloride Int J Pharm Technol Res 2 2010 2081 2089
64. A.I. Blazek-Walsh, and D.G. Rhodes SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes Pharm Res 18 2001 656 661
65. E. Farkas, R. Schubert, and R. Zelko Effect of beta sitosterol on the characteristics of vesicular gels containing chlorhexidine Int J Pharm 278 2004 63 70
66. B. Vora, A.J. Khopade, and N.K. Jain Pro niosome based transdermal delivery of levonorgestrel for effective contraception J Control Release 54 1985 149
67. H.E. Hofland, J.A. Bouwstra, H.E. Bodde, F. Spies, and H.E. Junginger Interactions between liposome and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies Br J Dermatol 132 1985 853
68. N. Raghavachari, and W.E. Fahl Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles J Pharm Sci 91 2002 615
69. J.Y. Fang, C.T. Hong, W.T. Chiu, and Y.Y. Wang Effect of liposome and niosomes on skin permeation of enoxacin Int J Pharm 219 2001 61
70. S.N. Ciotti, and N. Weiner Follicular liposomal delivery systems J Liposome Res 12 2002 143
71. A. Manosroi, N. Khositsuntiwong, F. Gotz, R.G. Werner, and J. Manosroi Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nano vesicles J Liposome Res 19 2009 91
72. I. Baumgartner, N. Chronos, A. Comerota, T. Henry, J.P. Pasquet, and F. Finiels Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia Mol Ther 17 2009 914
73. N. Meykadeh, M. Alireza, Z. Wang, E.B. Tschakarjan, and U.R. Hengge Topical application of plasmid DNA to mouse and human skin J Mol Med 83 2005 897
74. A. Paul Noninvasive administration of protein antigen: transdermal immunization with bovine serum albumin in transfersomes Vaccine Res 4 1995 145 164
75. C.A. Hunter, T.F. Dolan, G.H. Coombs, and A.J. Baillie Vesicular systems (niosome and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis J Pharm Pharmacol 40 1988 161 165
76. I.F. Uchegbu The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumor models J Drug Target 3 1996 399 409
77. Z.S. Bayindir, and N. Yuksel Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery J Pharm Sci 99 2010 2049 2060
78. M.N. Azmin The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice J Pharm Pharmacol 37 1985 237 242
79. Y. Huang PEGylated synthetic surfactant vesicles (niosomes): novel carriers for oligo nucleotides J Mater Sci Mater Med 19 2008 607 614
80. G. Abdelbary, and N. El-Gendy Niosome encapsulated gentamicin for ophthalmic controlled delivery AAPS PharmSciTech 9 2008 740 747
81. C. Terzanoa, L. Allegrab, F. Alhaiquec, C. Marianeccic, and M. Carafad Non-phospholipid vesicles for pulmonary glucocorticoid delivery Eur J Pharm Biopharm 59 2005 57 62
82. M. Bragagnia, N. Menninia, and C. Ghelardinib Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting, P. mura J Pharm Pharm Sci 15 2012 184 196